Hubei Fuxing Science and Technology Co (000926) Fair Value & Analysis
Real Estate · CN · Market cap 3.4B CNY
Fair value as of: Jul 25, 2026
From 9 valuation models · updated 16 days ago
Fair value updated Jul 25, 2026, revised from ¥4.98 to ¥4.95 (−0.6%) since Jun 26, 2026. Share price +10.8% over the past month.
Below-average quality, screening 129% undervalued on our models.
What matters now
- The large discount to fair value meets weak quality (43/100). That raises the risk this is a value trap rather than a bargain.
- The price is below even our cautious bear case (¥4.04). The market is more pessimistic than our downside scenario.
- As a real-estate business, asset- and dividend-based methods carry more weight here than a standard DCF.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 25, 2026.
How to read this chart
60‑month range ¥1.81 – ¥5.06 · fair‑value band ¥4.04 – ¥5.94 · the ¥2.16 price screens below the ¥4.95 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Jul 25, 2026.
Analysis
Hubei Fuxing Science and Technology Co (000926) currently trades at ¥2.16, while our model-based Fair Value estimate is ¥4.95, implying the stock looks roughly 129.2% undervalued today. The Quality Score stands at 43/100 (below-average quality), in the Real Estate sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium), always confirm before acting.
Trailing-twelve-month revenue stands at 3.9B CNY. Revenue grew 16.5% year over year. It earns a return on equity of -51.7%. Net debt stands at 2.1B CNY. Fundamentals as of Jul 25, 2026
Our scenario range runs from ¥4.04 (bear case) to ¥5.94 (bull case); at ¥2.16, the current price sits below that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 38% below its 52-week high and 15% above its 52-week low, currently below its 200-day average. For context, the median of 10 Real Estate peers we cover trades at 32% fair-value upside, at 129%, 000926 screens cheaper than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 9 models by family
Widest divergence: DCF Models (¥5.73) versus Asset-Based (¥2.26). Highest evidence: Growth DCF (80).
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Jul 25, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 47 · Market factors (momentum, volatility) 38
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
Hubei Fuxing Science and Technology Co.,Ltd engages in the real estate development business in China and internationally. The company is involved real estate development, as well as researches and develops metal products.
Full company description
Hubei Fuxing Science and Technology Co.,Ltd engages in the real estate development business in China and internationally. The company is involved real estate development, as well as researches and develops metal products. It also offers radial tire steel cord, steel wire, steel wire rope, steel strand, and other products that are used in tire industry, prestressed engineering of highways and bridges, transportation, communications, aviation, navigation, electric power, coal, construction, petrochemical, and agriculture fields. The company was founded in 1993 and is headquartered in Hanchuan, China.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Hubei Fuxing Science and Technology Co reported revenue of ¥3.8B in FY2025 versus ¥12.5B in FY2021, a compound −25.6%/yr. Reported net income was −¥4.1B in FY2025.
Watch 000926: get an alert when its fair value changes →
Peer Group
Real Estate - Development · 588 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Real Estate - Development median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Real Estate - Development stocks, each showing price versus our Fair Value estimate (as of Jul 25, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| DLF Limited DLF | ₹657.75 | ₹159.49 | -76% |
| Lodha Developers Limited LODHA | ₹1,188 | ₹583.43 | -51% |
| PT Pantai Indah Kapuk Dua Tbk, PANI | 6,125 IDR | 1,330 IDR | -78% |
| Oberoi Realty Limited OBEROIRLTY | ₹1,925 | ₹1,183 | -39% |
| Godrej Properties Limited GODREJPROP | ₹2,102 | ₹1,044 | -50% |
| PT Jaya Real Property, Tbk., JRPT | 1,080 IDR | 1,674 IDR | +55% |
| PT Bumi Serpong Damai Tbk, BSDE | 555.00 IDR | 1,388 IDR | +150% |
| PT Sentul City Tbk, BKSL | 64.00 IDR | 84.16 IDR | +32% |
| PT Ciputra Development Tbk, CTRA | 555.00 IDR | 1,388 IDR | +150% |
| PT Duta Pertiwi Tbk DUTI | 4,100 IDR | 6,239 IDR | +52% |
Compare Hubei Fuxing Science and Technology Co with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Real Estate stocks →
Frequently asked questions
Is Hubei Fuxing Science and Technology Co (000926) overvalued or undervalued?
What is the fair value of 000926?
What is the quality score of 000926?
What is the revenue of Hubei Fuxing Science and Technology Co (000926)?
What is the net profit margin of 000926?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track Hubei Fuxing Science and Technology Co and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.